Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Disintegration Time of Nurofen Ibuprofen ODT in Healthy Volunteers
NCT03658720Phase 1Terminated
- Sponsor
- Reckitt
- Start
- Dec 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen in pain, fever and inflammation (2 arms), sponsored by Reckitt. Primary endpoint: Tablet disintegration time at Day 1. Started Dec 2017; status: terminated.
02
Drugs
ibuprofen
03
Conditions
painfeverinflammation
Beyond the preview
Go deeper on NCT03658720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03658720.